R&D Strength

MORE +
scroll down

2017.09


Xian Xuan Yu Zijin Pharmaceutical Co., Ltd. has been established and is now operational. Registered capital: 5 million yuan.

Urbanization unleashes grassroots demand, presenting opportunities for the medical device sector.


Although the “strong start” that many investors had been anticipating for the Year of the Snake did not materialize, the market’s pullback couldn’t stem the remarkable surge in the pharmaceutical sector.

Focus on institutional development and improve the regulatory framework for medical devices.


The SFDA has actively promoted the revision of the "Regulations on the Supervision and Administration of Medical Devices," organizing and participating in numerous special meetings.

The Ministry of Health and five other departments jointly issued the "Guidelines for Centralized Procurement of High-Value Medical Consumables (Trial)."


Procurement of high-value medical consumables across various regions suffers from issues such as low concentration, high procurement prices

Centralized procurement takes off—high-value medical devices may soon carry low-price labels.


In accordance with the requirements of six departments, including the Ministry of Health, high-value medical consumables such as vascular intervention devices

Enforcement Q&A on Medical Device Manufacturing Addresses


In the registration management of medical devices, the manufacturing address is more critical than the registration address. According to the relevant provisions of the "Measures for the Registration and Administration of Medical Devices"
< 1...6789 > proceed page